HRI depletion cooperates with pharmacologic inducers to elevate fetal hemoglobin and reduce sickle cell formation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HRI depletion cooperates with pharmacologic inducers to elevate fetal hemoglobin and reduce sickle cell formation
Authors
Keywords
-
Journal
Blood Advances
Volume 4, Issue 18, Pages 4560-4572
Publisher
American Society of Hematology
Online
2020-09-22
DOI
10.1182/bloodadvances.2020002475
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression
- (2020) Peng Huang et al. BLOOD
- Understanding heterogeneity of fetal hemoglobin induction through comparative analysis of F and A erythroblasts
- (2020) Eugene Khandros et al. BLOOD
- HRI coordinates translation necessary for protein homeostasis and mitochondrial function in erythropoiesis
- (2019) Shuping Zhang et al. eLife
- A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
- (2019) Elliott Vichinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells
- (2018) Yankai Zhang et al. BLOOD
- Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch
- (2018) Nan Liu et al. CELL
- Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding
- (2018) Gabriella E. Martyn et al. NATURE GENETICS
- A Phase 3 Trial of l-Glutamine in Sickle Cell Disease
- (2018) Yutaka Niihara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells
- (2018) Jeremy D. Grevet et al. SCIENCE
- Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis
- (2018) Abdullah Kutlar et al. AMERICAN JOURNAL OF HEMATOLOGY
- Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa
- (2018) Léon Tshilolo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
- (2017) Kenneth I. Ataga et al. NEW ENGLAND JOURNAL OF MEDICINE
- A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
- (2016) Elizabeth A Traxler et al. NATURE MEDICINE
- Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2
- (2016) Jeffrey R. Shearstone et al. PLoS One
- Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin
- (2016) T. Masuda et al. SCIENCE
- Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation
- (2015) Erica B. Esrick et al. AMERICAN JOURNAL OF HEMATOLOGY
- Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/ -globin looping
- (2015) I. Krivega et al. BLOOD
- EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression
- (2015) A. Renneville et al. BLOOD
- Pomalidomide reverses -globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors
- (2015) B. M. Dulmovits et al. BLOOD
- Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease
- (2014) Eduard J. van Beers et al. AMERICAN JOURNAL OF HEMATOLOGY
- Global transcriptome analyses of human and murine terminal erythroid differentiation
- (2014) X. An et al. BLOOD
- Heme-regulated eIF2 kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis
- (2012) R. N. V. S. Suragani et al. BLOOD
- Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib
- (2012) P. G. Richardson et al. BLOOD
- Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice
- (2011) S. E. Meiler et al. BLOOD
- Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease
- (2010) James E. Bradner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis
- (2009) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells
- (2008) Laure A. Moutouh-de Parseval et al. JOURNAL OF CLINICAL INVESTIGATION
- Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific RepressorBCL11A
- (2008) Vijay G. Sankaran et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now